Survodutide 10mg (10 Vials/kit): Dual GLP-1 & Glucagon Receptor Agonist for Metabolic & MASH Research

Survodutide (BI 456906) is a novel acylated synthetic peptide that acts as a dual agonist at both the glucagon-like peptide-1 receptor ($\text{GLP-1R}$) and the glucagon receptor ($\text{GCGR}$). Engineered with a C18 fatty diacid moiety, Survodutide balances balanced activation across both receptors, targeting metabolic pathways in both the central nervous system and the liver. Sourcing Survodutide 10mg (10 Vials/kit) provides metabolic researchers, hepatology laboratories, and preclinical endocrinology units with a high-purity analytical reagent designed to study energy expenditure elevation, hepatic lipid clearance, and metabolic dysfunction-associated steatohepatitis ($\text{MASH}$ / $\text{NASH}$) regression in vitro and in vivo.

While single-target $\text{GLP-1R}$ agonists primarily act on hypothalamic centers to reduce calorie intake and improve glucose-dependent insulin secretion, the integration of glucagon receptor ($\text{GCGR}$) agonism introduces a distinct metabolic vector. Direct activation of hepatic $\text{GCGR}$ upregulates mitochondrial $\beta$-oxidation of fatty acids, increases resting metabolic rate, and reduces intrahepatic triglyceride accumulation. Simultaneously, the $\text{GLP-1R}$ agonistic activity counteracts potential glucagon-induced hyperglycemia:

Maintaining batch stability and exact stoichometric concentration is vital for evaluating receptor internalizing kinetics, gene expression profiling, and liver tissue explant assays. The Survodutide 10mg (10 Vials/kit) format delivers a total yield of 100mg active research peptide material (10mg per vial) divided across ten individual USP Type I borosilicate glass vials. Freeze-dried under sterile vacuum conditions, each vial contains a uniform lyophilized powder cake. This multi-vial kit structure enables research facilities to reconstitute precise working volumes as needed while keeping remaining stock preserved in deep-freeze conditions to protect against hydrolytic degradation.

Dual Agonism, Hepatic Lipid Metabolism, and Technical Profile

The primary scientific value of Survodutide 10mg (10 Vials/kit) stems from its dual GLP-1R/GCGR signaling balance, prolonged pharmacokinetic profile, and targeted hepatoprotective pathways:

• Dual GLP-1R / GCGR Receptor Agonism: Simultaneously engages central appetite regulatory centers and hepatic glucagon receptors to increase metabolic rate while suppressing calorie intake.

• Hepatic Steatosis & MASH Models: Accelerates intrahepatic lipid clearance, downregulating pro-inflammatory and fibrotic cascades in liver tissue research models.

• Albumin-Binding Acylation: C18 fatty acid chain modification facilitates reversible binding to circulating serum albumin, protecting the peptide against rapid enzymatic cleavage by dipeptidyl peptidase-4 ($\text{DPP-4}$).

• Enhanced Energy Expenditure: Glucagon receptor stimulation elevates basal energy throughput and thermogenesis without compromising glycemic stability.

• Ultra-High Chemical Purity ($\ge$99.0%): Manufactured via automated Solid-Phase Peptide Synthesis ($\text{SPPS}$) and purified using preparative High-Performance Liquid Chromatography ($\text{HPLC}$) to ensure complete removal of deletion sequences and synthesis byproducts.

Reconstitution Guidelines, Laboratory Storage Standards, and Quality Protocols

Achieving reproducible, publication-grade results when working with Survodutide 10mg (10 Vials/kit) requires strict adherence to standardized laboratory preparation and climate-controlled storage protocols.

Perform all reconstitution procedures inside a certified Class II Biosafety Cabinet:

1. Temperature Balancing: Allow the frozen Survodutide vial to adjust to ambient room temperature prior to solvent introduction to eliminate moisture condensation inside the glass container.

2. Septum Sanitization: Remove the protective plastic flip-cap and thoroughly wipe the synthetic rubber stopper with a fresh 70% isopropyl alcohol pad. Allow the surface to dry completely.

3. Slow Diluent Addition: Using a sterile syringe equipped with a fine-gauge needle, draw the required volume of Bacteriostatic Water (0.9% benzyl alcohol), Sterile Normal Saline (0.9% NaCl), or Phosphate-Buffered Saline (PBS). Direct the liquid stream against the inner glass wall so it trickles slowly over the lyophilized cake.

4. Gentle Hydration: Allow the diluent to fully hydrate the powder cake for 2 minutes. Gently roll the vial between your palms or swirl in smooth circular motions until clear. Never vortex or shake violently, as high-shear agitation can disrupt peptide tertiary structures and induce protein foaming.

5. Micro-Aliquot Strategy: For multi-week testing protocols, divide reconstituted liquid into sterile, single-use microcentrifuge tubes under aseptic conditions to prevent atmospheric oxidation and eliminate repeated freeze-thaw cycles.

Batch Quality Documentation & Traceability: Every production lot of Survodutide 10mg (10 Vials/kit) undergoes third-party analytical testing. High-Performance Liquid Chromatography (HPLC) chromatograms confirm component purity exceeding 99.0%, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms precise theoretical molecular mass. Each shipment includes a batch-specific Certificate of Analysis (COA) documenting chemical purity, residual solvent analysis, heavy metal screens, and bacterial endotoxin levels (<0.05 EU/mg) to satisfy institutional compliance requirements.

Strict Regulatory & Research Compliance Statement: Survodutide 10mg (10 Vials/kit) is produced, packaged, and distributed exclusively for in vitro laboratory research, academic experimentation, chemical synthesis, and preclinical research. Survodutide 10mg (10 Vials/kit) is strictly not intended, formulated, or approved for human or animal consumption, therapeutic medical treatment, clinical diagnostic work, or cosmetic applications. All handling must be conducted by certified research personnel operating within equipped laboratory facilities in compliance with OSHA workplace safety regulations and institutional biosafety protocols.